EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial De-Escalation in Critically Ill Patients

Eloisa Sofia Tanzarella, Salvatore Lucio Cutuli iD, Gianmarco Lombardi, Fabiola Cammarota, Alessandro Caroli, Emanuele Franchini, Elena Sancho Ferrando iD, Domenico Luca Grieco iD, Massimo Antonelli, Gennaro De Pascale iD

Antibiotics · 19.04.2024 · 13 (4) · 375

DOI: 10.3390/antibiotics13040375 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 19.04.2024. Verfasst von Eloisa Sofia Tanzarella und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Ita…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial de-escalation (ADE) is defined as the discontinuation of one or more antimicrobials in empirical therapy, or the replacement of a broad-spectrum antimicrobial with a narrower-spectrum antimicrobial. The aim of this review is to provide an overview of the available literature on the effectiveness and safety of ADE in critically ill patients, with a focus on special conditions such as anti-fungal therapy and high-risk categories. Although it is widely considered a safe strategy for antimicrobial stewardship (AMS), to date, there has been no assessment of the effect of de-escalation on the development of resistance. Conversely, some authors suggest that prolonged antibiotic treatment may be a side effect of de-escalation, especially in high-risk categories such as neutropenic critically ill patients and intra-abdominal infections (IAIs). Moreover, microbiological documentation is crucial for increasing ADE rates in critically ill patients with infections, and efforts should be focused on exploring new diagnostic tools to accelerate pathogen identification. For these reasons, ADE can be safely used in patients with infections, as confirmed by high-quality and reliable microbiological samplings, although further studies are warranted to clarify its applicability in selected populations.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial de-escalationantimicrobial stewardshipcritical illnessdiagnostic toolsempirical therapy

Autor:innen und Institutionen

  • Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Medical Intensive Care Unit, Hospital Clinic Barcelona, 08036 Barcelona, Spain.

ORCID-Profile: Salvatore Lucio Cutuli, Elena Sancho Ferrando, Domenico Luca Grieco, Gennaro De Pascale

Zitieren

APA

Tanzarella, E. S., Cutuli, S. L., Lombardi, G., Cammarota, F., Caroli, A., Franchini, E., Sancho Ferrando, E., Grieco, D. L., Antonelli, M., & De Pascale, G. (2024). Antimicrobial De-Escalation in Critically Ill Patients. Antibiotics, 13(4), 375. https://doi.org/10.3390/antibiotics13040375

Vancouver

Tanzarella ES, Cutuli SL, Lombardi G, Cammarota F, Caroli A, Franchini E, et al. Antimicrobial De-Escalation in Critically Ill Patients. Antibiotics. 2024;13(4):375. doi:10.3390/antibiotics13040375

BibTeX
@article{Tanzarella2024,
  author = {Tanzarella, Eloisa Sofia and Cutuli, Salvatore Lucio and Lombardi, Gianmarco and Cammarota, Fabiola and Caroli, Alessandro and Franchini, Emanuele and Sancho Ferrando, Elena and Grieco, Domenico Luca and Antonelli, Massimo and De Pascale, Gennaro},
  title = {Antimicrobial De-Escalation in Critically Ill Patients},
  journal = {Antibiotics},
  year = {2024},
  volume = {13},
  number = {4},
  pages = {375},
  doi = {10.3390/antibiotics13040375}
}
Kostenlos starten →